{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T17:12:39Z","timestamp":1788541959055,"version":"build-2803163510"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T00:00:00Z","timestamp":1686873600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oral. Health"],"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>Benzydamine is a compound indicated in the treatment of symptoms of irritation\/inflammation of the oropharyngeal cavity, including those associated with pain. Objectives of this expert opinion narrative review is to summarize current indicated benzydamine applications and elicit further ones to be explored.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and methods<\/jats:title><jats:p>In this expert opinion paper, evidences underlying the mechanism of action and clinical application of benzydamine are reviewed. Insights are also provided on possible new clinical applications of the drug and new formulations.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Current recognized indications of benzydamine include: relief of symptoms associated with inflammatory conditions of the mouth and oropharynx, symptomatic treatment of gingivitis and stomatitis, oral mucositis induced by chemotherapy and\/or radiotherapy and post operative sore throat. In addition, among new applications that need to be explored experts embed: oral lichen planus, burning mouth syndrome, post intubation sore throat, antifungal action and new anticancer target agents induced mucositis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Benzydamine is a very versatile compound able to play an auxiliary and adjuvant role in the prevention and treatment of oral cavity\/oropharynx disorders. According to experts\u2019 opinion there is the need to design clinical trials to highlight novel possible applications of benzydamine and implemented translational analyses to fine-tune patients\u2019 selection and open future research scenarios.<\/jats:p><\/jats:sec>","DOI":"10.3389\/froh.2023.1191319","type":"journal-article","created":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T06:09:28Z","timestamp":1686895768000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["The present and the future of benzydamine: expert opinion paper"],"prefix":"10.3389","volume":"4","author":[{"given":"Paolo","family":"Bossi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Gurizzan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orlando","family":"Guntinas-Lichius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Razvan","family":"Hainarosie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Lancini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,6,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s10787-998-0026-0","article-title":"Pharmacology of benzydamine","volume":"6","author":"Quane","year":"1998","journal-title":"Inflammopharmacology"},{"key":"B2","first-page":"229","article-title":"Benzydamine: a critical review of clinical data","volume":"7","author":"Mahon","year":"1985","journal-title":"Int J Tissue React"},{"key":"B3","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1186\/s12875-022-01901-w","article-title":"International delphi-based consensus on the appropriate use and effect of benzydamine hydrochloride in the treatment of sore throat","volume":"23","author":"Passali","year":"2022","journal-title":"BMC Prim Care"},{"key":"B4","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s12875-022-01762-3","article-title":"Benzydamine hydrochloride for the treatment of sore throat and irritative\/inflammatory conditions of the oropharynx: a cross-national survey among pharmacists and general practitioners","volume":"23","author":"Passali","year":"2022","journal-title":"BMC Prim Care"},{"key":"B5","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1006\/cyto.1996.0094","article-title":"Inhibition of inflammatory cytokine production and protection against endotoxin toxicity by benzidamine","volume":"8","author":"Sironi","year":"1996","journal-title":"Cytokine"},{"key":"B6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s005990070028","article-title":"Differential effect of benzydamine on pro- versus anti-inflammatory cytokine production: lack of inhibition of interleukin-10 and interleukin-1 receptor antagonist","volume":"30","author":"Sironi","year":"2000","journal-title":"Int J Clin Lab Res"},{"key":"B7","first-page":"851","article-title":"Effect of econazole and benzydamine on sensory neurons in culture","volume":"67","author":"Mathivanan","year":"2016","journal-title":"J Physiol Pharmacol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"504a","DOI":"10.1016\/j.bpj.2021.11.262","article-title":"Benzydamine inhibits neuronal excitability induced by inflammatory mediators to relieve pain","volume":"121","author":"Ferrer-Montiel","year":"2022","journal-title":"Biophys J"},{"key":"B9","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1080\/1120009X.1992.11739190","article-title":"Antimicrobial activity of benzydamine, a non-steroid anti-inflammatory agent","volume":"4","author":"Fanaki","year":"1992","journal-title":"J Chemother"},{"key":"B10","first-page":"320","article-title":"Antibacterial activity of benzydamine and antibiotic-benzydamine combinations against multifold resistant clinical isolates","volume":"46","author":"Fanaki","year":"1996","journal-title":"Arzneimittelforschung"},{"key":"B11","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1111\/anae.14224","article-title":"Topical benzydamine hydrochloride for prevention of postoperative sore throat in adults undergoing tracheal intubation for elective surgery: a systematic review and meta-analysis","volume":"73","author":"Kuriyama","year":"2018","journal-title":"Anaesthesia"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e33367","DOI":"10.1097\/MD.0000000000033367","article-title":"Comparative evaluation of rapidity of action of benzydamine hydrochloride 0.3% oromucosal spray and benzydamine hydrochloride 3 mg lozenges in patients with acute sore throat: a phase IV randomized trial","volume":"102","author":"Valerio","year":"2023","journal-title":"Medicine"},{"key":"B13","doi-asserted-by":"publisher","first-page":"5701","DOI":"10.1007\/s00520-021-06048-5","article-title":"The role of benzydamine in prevention and treatment of chemoradiotherapy-induced mucositis","volume":"29","author":"Nicolatou-Galitis","year":"2021","journal-title":"Support Care Cancer"},{"key":"B14","doi-asserted-by":"publisher","first-page":"4423","DOI":"10.1002\/cncr.33100","article-title":"MASCC\/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy","volume":"126","author":"Elad","year":"2020","journal-title":"Cancer"},{"key":"B15","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.medcle.2017.09.013","article-title":"Treatment of oral lichen planus. Systematic review and therapeutic guide","volume":"149","author":"Garc\u00eda-Pola","year":"2017","journal-title":"Med Cl\u00ednica"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1111\/odi.12634","article-title":"Interventions for the management of oral lichen planus: a review of the conventional and novel therapies","volume":"23","author":"Gupta","year":"2017","journal-title":"Oral Dis"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e827","DOI":"10.4317\/medoral.15.e827","article-title":"The use of topical corticoids in oral pathology","volume":"15","author":"Gonzalez-Moles","year":"2010","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"B18","article-title":"Burning mouth syndrome","volume":"2016","author":"Zakrzewska","year":"2016","journal-title":"BMJ Clin Evid"},{"key":"B19","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.clindermatol.2017.06.006","article-title":"A diagnostic and therapeutic approach to primary burning mouth syndrome","volume":"35","author":"Moghadam-Kia","year":"2017","journal-title":"Clin Dermatol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1177\/00220345221130025","article-title":"Treatments for burning mouth syndrome: a network meta-analysis","volume":"102","author":"Alvarenga-Brant","year":"2023","journal-title":"J Dent Res"},{"key":"B21","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/S1079-2104(99)70010-7","article-title":"Benzydamine hydrochloride oral rinses in management of burning mouth syndrome.","volume":"88","author":"Sardella","year":"1999","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endont"},{"key":"B22","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1111\/anae.13438","article-title":"Postoperative sore throat: a systematic review","volume":"71","author":"El-Boghdadly","year":"2016","journal-title":"Anaesthesia"},{"key":"B23","first-page":"121","article-title":"Benzydamine for the prevention of pharyngo-laryngeal pathology following tracheal intubation","volume":"9","author":"Mazzarella","year":"1987","journal-title":"Int J Tissue React"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1007\/s12630-015-0432-x","article-title":"Effect of prophylactic benzydamine hydrochloride on postoperative sore throat and hoarseness after tracheal intubation using a double-lumen endobronchial tube: a randomized controlled trial","volume":"62","author":"Chang","year":"2015","journal-title":"Can J Anaesth"},{"key":"B25","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12871-020-00995-y","article-title":"Effects of benzydamine hydrochloride on postoperative sore throat after extubation in children: a randomized controlled trial","volume":"20","author":"Yhim","year":"2020","journal-title":"BMC Anesthesiol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"3613","DOI":"10.1007\/s00784-021-04330-8","article-title":"Effects of benzydamine and mouthwashes containing benzydamine on Candida albicans adhesion, biofilm formation, regrowth, and persistence","volume":"26","author":"Ardizzoni","year":"2022","journal-title":"Clin Oral Investig"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1007\/s00520-017-3629-4","article-title":"Oral mucosal changes induced by anticancer targeted therapies and immune checkpoint inhibitors","volume":"25","author":"Vigarios","year":"2017","journal-title":"Support Care Cancer"},{"key":"B28","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.oraloncology.2012.11.008","article-title":"A review of oral toxicity associated with mTOR inhibitor therapy in cancer patients","volume":"49","author":"Martins","year":"2013","journal-title":"Oral Oncol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/S1470-2045(17)30109-2","article-title":"Prevention of everolimus-related stomatitis in women with hormone receptor-positive, HER2-negative metastatic breast cancer using dexamethasone mouthwash (SWISH): a single-arm, phase 2 trial","volume":"18","author":"Rugo","year":"2017","journal-title":"Lancet Oncol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1177\/0269216308095701","article-title":"Pain assessment tools in palliative care: an urgent need for consensus","volume":"22","author":"Hjermstad","year":"2008","journal-title":"Palliat Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1515\/sjpain-2018-0012","article-title":"The validity of pain intensity measures: what do the NRS, VAS, VRS, and FPS-R measure?","volume":"18","author":"Thong","year":"2018","journal-title":"Scand J Pain"},{"key":"B32","doi-asserted-by":"publisher","first-page":"00.1","DOI":"10.1136\/bmjspcare-2016-001137","article-title":"Can patient-reported measurements of pain be used to improve cancer pain management? A systematic review and meta-analysis","volume":"7","author":"Adam","year":"2017","journal-title":"BMJ Support Palliat Care"},{"key":"B33","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/papr.12711","article-title":"PROMs for pain in adult cancer patients: a systematic review of measurement properties","volume":"19","author":"Abahussin","year":"2019","journal-title":"Pain Pract"},{"key":"B34","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1007\/s11914-020-00611-5","article-title":"How to include patient-reported outcome measures in clinical trials","volume":"18","author":"McGee","year":"2020","journal-title":"Curr Osteoporos Rep"}],"container-title":["Frontiers in Oral Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/froh.2023.1191319\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T13:01:02Z","timestamp":1687179662000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/froh.2023.1191319\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,16]]},"references-count":34,"alternative-id":["10.3389\/froh.2023.1191319"],"URL":"https:\/\/doi.org\/10.3389\/froh.2023.1191319","relation":{},"ISSN":["2673-4842"],"issn-type":[{"value":"2673-4842","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,16]]},"article-number":"1191319"}}